Thomas S. Harrison

25.0k citations

189 papers · 11.3k indexed · 4 hit papers · h-index 53

Impact in

Infectious Diseases top 0.05%
- Antifungal resistance and susceptibility
- Tuberculosis Research and Epidemiology
Epidemiology top 0.05%
- Fungal Infections and Studies
- Nail Diseases and Treatments
- Pneumocystis jirovecii pneumonia detection and treatment
- Cytomegalovirus and herpesvirus research

Papers in

Infectious Diseases 152
- Antifungal resistance and susceptibility 130
- Tuberculosis Research and Epidemiology 15
Epidemiology 170
- Fungal Infections and Studies 150
- Nail Diseases and Treatments 60
- Pneumocystis jirovecii pneumonia detection and treatment 35
- Cytomegalovirus and herpesvirus research 23
- Mycobacterium research and diagnosis 8

Co-authors: Joseph N Jarvis Tihana Bicanic Graeme Meintjes Angela Loyse John R. Perfect Olivier Lortholary Robert A. Larsen Robin Wood
Journals: Clinical Infectious Diseases (26 papers)Antimicrobial Agents and Chemotherapy (11 papers)Journal of Infection (11 papers)The Journal of Infectious Diseases (9 papers)Medical Mycology (8 papers)
Partner nations: United Kingdom United States South Africa

In The Last Decade

Thomas S. Harrison

185 papers receiving 11.1k citations

Hit Papers

align trajectories log scale

The importance of antimicrobial resistance in medical mycology 2022 · 136 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Communications
2022 Nature Reviews Microbiology
2017 The Lancet Infectious Diseases
2010 Clinical Infectious Diseases

Peers

Countries citing papers authored by Thomas S. Harrison

Since Specialization

Citations

This map shows the geographic impact of Thomas S. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas S. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas S. Harrison more than expected).

Fields of papers citing papers by Thomas S. Harrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas S. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas S. Harrison. The network helps show where Thomas S. Harrison may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas S. Harrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas S. Harrison Line = papers co-authored together Thomas S. Harrison links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cryptococcosis—a systematic review to inform the World Health Organization Fungal Priority Pathogens List Medical Mycology ·Aiken Dao, Hannah Yejin Kim, Iris Därmann, Sarah Kidd, Hatim Sati, John R. Perfect, Tania C. Sorrell, Thomas S. Harrison, Volker Rickerts, Valeria Gigante, Ana Alastruey‐Izquierdo, Jan‐Willem C. Alffenaar, C. Orla Morrissey, Sharon C.‐A. Chen, Justin Beardsley	2024	12
2	A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity npj Vaccines ·Junhua Zhang, Ulf Sefastsson, Matthew J. Paul, Thomas S. Harrison, Andrea M. Cooper, Rajko Reljić	2024	3
3	Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens Medical Mycology ·清興良, Hannah Yejin Kim, Sophie L. Stocker, Sarah Kidd, Ana Alastruey‐Izquierdo, Aiken Dao, Thomas S. Harrison, Retno Wahyuningsih, Volker Rickerts, John R. Perfect, David W. Denning, Márcio Nucci, Alessandro Cassini, Justin Beardsley, Valeria Gigante, Hatim Sati, C. Orla Morrissey, Jan‐Willem C. Alffenaar	2024	13
4	Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris In Vitro Antimicrobial Agents and Chemotherapy ·忠士松元, 郭烈华, Tihana Bicanic, Martin Hoenigl, Alistair J. P. Brown, Thomas S. Harrison, Elaine Bignell	2023	16
5	Genetic diversity and microevolution in clinical Cryptococcus isolates from Cameroon Medical Mycology ·Poppy Sephton-Clark, Elvis Temfack, Jennifer L. Tenor, Dena L. Toffaletti, Angela Loyse, Síle F. Molloy, John R. Perfect, Tihana Bicanic, Thomas S. Harrison, Olivier Lortholary, Charles Kouanfack, Christina A. Cuomo	2023	1
6	The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda PLoS neglected tropical diseases ·David S. Lawrence, Agnes Ssali, Jesús García-Guadalupe, 渡邉直人, Natalie A. Larew, Thomas S. Harrison, David B. Meya, Joseph N Jarvis, Janet Seeley	2022	6
7	Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana Biomedicines ·祐子諸石, Sikhulile Moyo, 康仁上田, Ava Kennerly, V. A. Artemyuk, E Schiefer, Kwana Lechiile, Tshepo Leeme, David S. Lawrence, Ishmael Kasvosve, Rosemary Musonda, 和幸山岡, Thomas S. Harrison, Joseph N Jarvis, Simani Gaseitsiwe	2022	3
8	Tackling the emerging threat of antifungal resistance to human health Nature Reviews Microbiology ·Matthew C. Fisher, Ana Alastruey‐Izquierdo, Judith Berman, Tihana Bicanic, Elaine Bignell, Paul Bowyer, Michael Bromley, Roger J. M. Brüggemann, Gary Garber, Oliver A. Cornely, Sarah J. Gurr, Thomas S. Harrison, Ed J. Kuijper, Johanna Rhodes, Donald C. Sheppard, Adilia Warris, P. Lewis White, Jianping Xu, Bas J. Zwaan, Paul E. Verweij Hit paper breakdown →	2022	675
9	The importance of antimicrobial resistance in medical mycology Nature Communications ·Neil A. R. Gow, M A Lohse, Judith Berman, Alix T. Coste, Christina A. Cuomo, David S. Perlin, Tihana Bicanic, Thomas S. Harrison, Nathan P. Wiederhold, Michael Bromley, Tom Chiller, Nicole Viehstaedt Hit paper breakdown →	2022	136
10	Genomic Variation across a Clinical Cryptococcus Population Linked to Disease Outcome mBio ·Poppy Sephton-Clark, Jennifer L. Tenor, Dena L. Toffaletti, Thavindu Ushan, Charles Giamberardino, Síle F. Molloy, M. Ostrogorsk, Adrienne K Chan, Ahmad G Ahanga, Robert S. Heyderman, Mina C. Hosseinipour, Newton Kalata, Cecilia Kanyama, Maria Kownacka, Johnson Le, Henry C. Mwandumba, Thomas S. Harrison, Tihana Bicanic, John R. Perfect, Christina A. Cuomo	2022	28
11	HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana Viruses ·祐子諸石, Sikhulile Moyo, 吳璧如, Du Chen-Hsun, Cairns, Laura Oliva Sánchez-Nupan, Kwana Lechiile, Tshepo Leeme, David S. Lawrence, Rosemary Musonda, Ishmael Kasvosve, Thomas S. Harrison, Joseph N Jarvis, Simani Gaseitsiwe	2020	2
12	Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans Open Forum Infectious Diseases ·Shichina Kannambath, Joseph N Jarvis, Rachel Wake, Nicky Longley, Angela Loyse, Vasiliki Matzaraki, Raúl Aguirre‐Gamboa, Cisca Wijmenga, Ronan Doyle, Maria Paximadis, Caroline T. Tiemessen, Vinod Kumar, Alan Pittman, Graeme Meintjes, Thomas S. Harrison, Mihai G. Netea, Tihana Bicanic	2020	13
13	A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine Antimicrobial Agents and Chemotherapy ·Edwin Langi, Simbarashe Zvada, Paolo Denti, Mark Hatherill, Salome Charalambous, Stanley Mungofa, Rodney Dawson, Susan E. Dorman, Huijin Cheon, Lubbe Wiesner, Amina Jindani, Thomas S. Harrison, Adeniyi Olagunju, Deirdre Egan, Andrew Owen, Helen McIlleron	2019	20
14	Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence mBio ·Yoon‐Dong Park, Joseph N Jarvis, Guowu Hu, Sarah E. Davis, Jin Qiu, Nannan Zhang, G K Henry, Angela Loyse, Paul J. Gardina, Tibor Vályi-Nagy, Timothy G. Myers, Thomas S. Harrison, Tihana Bicanic, Peter R. Williamson	2018	4
15	The Cryptococcus neoformans Titan cell is an inducible and regulated morphotype underlying pathogenesis PLoS Pathogens ·Ivy M. Dambuza, Thomas A. Drake, Angie Katherine Zamora Guaba, Xin Zhou, Joao Correia, L. Smith, Nathalie Legrave, Tim Rasmussen, Matthew C. Fisher, Tihana Bicanic, Thomas S. Harrison, Marcel Jaspars, Robin C. May, Gordon D. Brown, Raif Yuecel, Donna M. MacCallum, Elizabeth R. Ballou	2018	117
16	A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection G3 Genes Genomes Genetics ·Johanna Rhodes, Mathew A. Beale, Mathieu Vanhove, Joseph N Jarvis, Shichina Kannambath, John Simpson, Pei-Ting Li, Graeme Meintjes, Thomas S. Harrison, Matthew C. Fisher, Tihana Bicanic	2017	66
17	Cryptococcal meningitis British Journal of Hospital Medicine ·Damien Ming, Thomas S. Harrison	2017	4
18	The Phenotype of the Cryptococcus-Specific CD4+ Memory T-Cell Response Is Associated With Disease Severity and Outcome in HIV-Associated Cryptococcal Meningitis The Journal of Infectious Diseases ·Joseph N Jarvis, Joseph P. Casazza, Marlyn Boke, Graeme Meintjes, Stephen D Lawn, Stuart M. Levitz, Thomas S. Harrison, Richard A. Koup	2013	105
19	Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice Journal of Antimicrobial Chemotherapy ·Ann Sturdy, Anna L. Goodman, Ricardo J. José, Angela Loyse, Lucía Verdegay, Onn Min Kon, Martin Dedicoat, Thomas S. Harrison, Laurence John, Marc Lipman, Graham Cooke	2011	69
20	Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America Clinical Infectious Diseases ·John R. Perfect, William E. Dismukes, Françoise Dromer, David L. Goldman, John R. Graybill, Richard J. Hamill, Thomas S. Harrison, Robert A. Larsen, Olivier Lortholary, H. Spängler, Peter G. Pappas, William G. Powderly, Nina Singh, Jack D. Sobel, Tania C. Sorrell Hit paper breakdown →	2010	1749

About Thomas S. Harrison

Thomas S. Harrison is a scholar working on Infectious Diseases, Epidemiology, Virology, Small Animals and Immunology, having authored 189 papers that have together received 11.3k indexed citations. Recurring topics across this work include Fungal Infections and Studies (150 papers), Antifungal resistance and susceptibility (130 papers), Nail Diseases and Treatments (60 papers), Pneumocystis jirovecii pneumonia detection and treatment (35 papers), Cytomegalovirus and herpesvirus research (23 papers), Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (8 papers) and HIV/AIDS oral health manifestations (6 papers). The work is most often cited by research in Infectious Diseases (9.0k citations), Epidemiology (9.5k citations), Microbiology (474 citations), Microbiology (52 citations) and Small Animals (361 citations). Thomas S. Harrison has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Joseph N Jarvis, Tihana Bicanic, Graeme Meintjes, Angela Loyse, John R. Perfect, Olivier Lortholary, Robert A. Larsen, Robin Wood, Stuart M. Levitz and Françoise Dromer. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Infection, The Journal of Infectious Diseases and Medical Mycology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact